National Pension Service Raises Holdings in Medtronic PLC $MDT

National Pension Service increased its position in Medtronic PLC (NYSE:MDT) by 2.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,954,142 shares of the medical technology company’s stock after acquiring an additional 63,554 shares during the quarter. National Pension Service owned about 0.23% of Medtronic worth $281,352,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Brighton Jones LLC grew its stake in Medtronic by 1,368.0% in the 4th quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company’s stock valued at $3,194,000 after buying an additional 37,265 shares in the last quarter. Sivia Capital Partners LLC boosted its holdings in shares of Medtronic by 9.6% in the second quarter. Sivia Capital Partners LLC now owns 4,356 shares of the medical technology company’s stock worth $380,000 after acquiring an additional 381 shares during the period. PFG Investments LLC grew its position in shares of Medtronic by 4.4% in the second quarter. PFG Investments LLC now owns 8,575 shares of the medical technology company’s stock valued at $747,000 after purchasing an additional 360 shares in the last quarter. SOA Wealth Advisors LLC. raised its stake in shares of Medtronic by 282.8% during the 2nd quarter. SOA Wealth Advisors LLC. now owns 777 shares of the medical technology company’s stock valued at $68,000 after purchasing an additional 574 shares during the period. Finally, Patriot Financial Group Insurance Agency LLC lifted its holdings in Medtronic by 17.8% during the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 32,372 shares of the medical technology company’s stock worth $2,822,000 after purchasing an additional 4,886 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on MDT shares. Jefferies Financial Group reiterated a “hold” rating and set a $110.00 price target on shares of Medtronic in a research report on Wednesday, November 19th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Medtronic in a research note on Monday, December 29th. Stifel Nicolaus increased their target price on shares of Medtronic from $90.00 to $105.00 and gave the stock a “hold” rating in a research note on Thursday, October 9th. Citigroup raised their price target on shares of Medtronic from $101.00 to $112.00 and gave the company a “buy” rating in a report on Tuesday, October 7th. Finally, UBS Group upped their price target on shares of Medtronic from $95.00 to $102.00 and gave the stock a “neutral” rating in a report on Wednesday, November 19th. Fifteen analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Medtronic currently has an average rating of “Moderate Buy” and a consensus target price of $110.28.

Medtronic Trading Up 1.9%

Shares of MDT stock opened at $102.96 on Friday. The business has a 50-day moving average price of $99.60 and a two-hundred day moving average price of $95.64. Medtronic PLC has a 12-month low of $79.55 and a 12-month high of $106.33. The company has a quick ratio of 1.80, a current ratio of 2.42 and a debt-to-equity ratio of 0.57. The firm has a market cap of $131.99 billion, a P/E ratio of 27.75, a price-to-earnings-growth ratio of 2.66 and a beta of 0.71.

Medtronic (NYSE:MDT) last announced its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.05. The company had revenue of $8.96 billion for the quarter, compared to analysts’ expectations of $8.86 billion. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.Medtronic’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period last year, the firm posted $1.26 EPS. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. Equities analysts anticipate that Medtronic PLC will post 5.46 EPS for the current fiscal year.

Medtronic Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 16th. Investors of record on Friday, December 26th were issued a dividend of $0.71 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $2.84 annualized dividend and a dividend yield of 2.8%. Medtronic’s dividend payout ratio (DPR) is currently 76.55%.

About Medtronic

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).